Mississippi · 86769

Measure Of Severe Acute Respiratory Syndrome Coronavirus 2 (covid-19) Antibody in Mississippi

Mississippi Medicare Avg
$41.14
0% below national avg
National Medicare Avg
$41.21
All states combined
Billed Charge (MS)
$99.25
What providers submit
Est. Commercial (MS)
$90.51
National avg: $92.31
Est. Cash / Self-Pay (MS)
$58.15
Typical self-pay discount

Estimated using RAND 2024 commercial-to-Medicare ratios. Actual prices vary by insurer, plan, and facility.

276
Services in MS
8
Providers
N/A
Min Payment
N/A
Max Payment

Mississippi Pricing in Context

In Mississippi, CPT code 86769 (Measure Of Severe Acute Respiratory Syndrome Coronavirus 2 (covid-19) Antibody) carries an average Medicare payment of $41.14 — 0% below the national benchmark of $41.21. 8 providers across the state submitted claims for this procedure in 2023, performing 276 total services. Individual payments in MS ranged from N/A at the low end to N/A at the high end, reflecting differences in provider setting (office vs. facility), modifiers, and the specific geographic locality code applied within the state.

The average billed charge in Mississippi is $99.25, which is the figure uninsured patients would most likely encounter before any negotiation or charity discount. Medicare, by statute, only reimburses the allowed amount — the balance between billed and paid is written off under provider participation agreements. Insured patients generally pay a negotiated rate that falls between these two figures; the exact amount depends on plan design, deductible status, and in-network participation. Because Mississippi sits below the national Medicare average, commercial rates in the state may also run lower than the US median.

Using RAND 2024 commercial-to-Medicare ratios for Immunology procedures, the estimated commercial insurance price in Mississippi lands near $90.51, with self-pay cash prices typically around $58.15. Before scheduling, patients can request a Good Faith Estimate under the No Surprises Act, compare cash rates from hospital Machine-Readable Files, and confirm whether the provider is in-network with their specific plan. This page presents CMS reference data for informational use; it does not constitute medical or financial advice.

Frequently Asked Questions

How much does Measure Of Severe Acute Respiratory Syndrome Coronavirus 2 (covid-19) Antibody cost in Mississippi?

The average Medicare payment for Measure Of Severe Acute Respiratory Syndrome Coronavirus 2 (covid-19) Antibody in Mississippi is $41.14, which is 0% below the national average of $41.21. Providers in MS typically bill $99.25 for this procedure.

What does Measure Of Severe Acute Respiratory Syndrome Coronavirus 2 (covid-19) Antibody cost with insurance in Mississippi?

With commercial insurance in Mississippi, Measure Of Severe Acute Respiratory Syndrome Coronavirus 2 (covid-19) Antibody costs an estimated $90.51. Without insurance, the estimated cash price is $58.15. These estimates are based on RAND 2024 commercial-to-Medicare ratios and vary by insurer, plan, and facility.

How many providers perform Measure Of Severe Acute Respiratory Syndrome Coronavirus 2 (covid-19) Antibody in Mississippi?

8 providers in Mississippi billed Medicare for Measure Of Severe Acute Respiratory Syndrome Coronavirus 2 (covid-19) Antibody in 2023, performing 276 total services. Medicare payments ranged from N/A to N/A depending on the provider.

Is Measure Of Severe Acute Respiratory Syndrome Coronavirus 2 (covid-19) Antibody cheaper in Mississippi than the national average?

Yes — Measure Of Severe Acute Respiratory Syndrome Coronavirus 2 (covid-19) Antibody costs 0% below the national average in Mississippi. The state average Medicare payment is $41.14 compared to $41.21 nationally. Factors like local cost of living, provider competition, and regional Medicare fee schedules all influence state-level pricing.

Related

Data sourced from the CMS Medicare Physician and Other Practitioners dataset. See our methodology for details. Retrieved and formatted by PlainProcedure Editorial